HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Consensus paper on peri-interventional and postinterventional stroke during cardiac catheter procedures].

Abstract
Stroke is a serious complication of percutaneous coronary intervention and atrial fibrillation ablation procedures and patients have a high likelihood of persistent neurological deficits. Although formal criteria speak against intravenous or intra-arterial thrombolysis due to pre-existing antithrombotic and anticoagulation therapy, the conditions for recanalizing therapy are optimal due to the occurrence of vessel occlusion in the catheter suite or the chest pain unit. Brain imaging and an interdisciplinary approach are mandatory. In cases of intracerebral vessel occlusion intra-arterial thrombolysis possibly in combination with mechanical clot fragmentation is the first choice therapy. The management of the patient is always an individual therapeutic decision based on stroke severity, the pretreatment with antithrombotic and anticoagulation drugs, the availability of a neuro-interventionalist and the qualification of the local team.
AuthorsJ Röther, U Laufs, M Böhm, S Willems, B Scheller, M Borggrefe, H Darius, M Endres, U Zeymer, H-C Diener, M Grond, W Hacke, M Forsting, M Schumacher, M Hennerici, DGK, DSG, DGNR, DGN
JournalDer Nervenarzt (Nervenarzt) Vol. 80 Issue 10 Pg. 1205-6, 1208-15 (Oct 2009) ISSN: 1433-0407 [Electronic] Germany
Vernacular TitleKonsensuspapier "Peri- und postinterventioneller Schlaganfall bei Herzkatheterprozeduren"
PMID19830471 (Publication Type: Consensus Development Conference, English Abstract, Journal Article)
Topics
  • Cardiac Catheterization (adverse effects)
  • Cardiac Surgical Procedures (adverse effects)
  • Germany
  • Humans
  • Practice Guidelines as Topic
  • Stroke (etiology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: